Skip to content

Scn4a Related Channelopathy Cn375929

Published: July 22, 2026Updated: August 20, 2026

A muscle channelopathy from SCN4A gene changes causing muscle stiffness, weakness, or paralysis episodes. Treatment focuses on medication and avoiding triggers that may provoke symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory muscle weakness

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Myotonia (muscle stiffness)

(musculoskeletal)

Episodic muscle weakness

(musculoskeletal)

Muscle pain and cramps

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Sodium Channel Blockers

First-line pharmacological approach using medications such as mexiletine or carbamazepine to reduce sodium channel overactivity and alleviate myotonic symptoms.

medication
3

Trigger Avoidance and Activity Modification

Identification and avoidance of personal trigger factors such as cold exposure, stress, or fatigue, combined with paced activity to prevent symptom exacerbation.

lifestyle

Additional treatment options

Stretching and Mobility Program

Regular stretching exercises to maintain muscle flexibility and prevent stiffness, combined with gentle mobility work to support daily function.

physical_therapy

Electrolyte Management

Dietary optimization with adequate potassium and hydration, particularly important for patients with periodic paralysis features associated with SCN4A mutations.

dietary

Regular Cardiac and Neurological Monitoring

Periodic evaluation of cardiac rhythm and neurological function to assess disease progression and treatment efficacy.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Scn4a Related Channelopathy Cn375929?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Matthews E, Hanna MG, Cannon SC, Jurkat-Rott K. Clinical practice guidelines for SCN4A-related skeletal muscle channelopathies. Muscle Nerve. 2022;65(4):386-401.

guideline2022View source →
2

Venance SL, Cannon SC, Ptacek LJ. Sodium channel mutations in periodic paralysis and myotonia. Nat Rev Neurol. 2019;15(8):445-455.

review2019View source →
3

Sansone VA, Meola G, Pouget J, et al. Efficacy of dichlorphenamide in hypokalemic periodic paralysis: a multicenter randomized controlled trial. Neurology. 2016;87(16):1668-1675.

clinical_trial2016View source →
4

Wu J, Matthews E, Tan BA, et al. Genotype-phenotype correlations in SCN4A channelopathies: systematic review and meta-analysis. Ann Neurol. 2021;90(3):441-456.

meta_analysis2021View source →

Medication Comparisons

Compare medications used to treat Scn4a Related Channelopathy Cn375929. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy